Sadly it’s not just patients who end up dying before DCVax-L gets approved but shareholders too. It happened to someone close to me and that shareholder was much younger though still a senior.
For what it’s worth I hope this stock pays off in time for you to enjoy the vindication and perhaps even the money.
Congrats on winning life’s race though, whatever happens with this investment. Most do not make it nearly so far.
Market Data 
Markets 
AI
